Antidiabetic effects of fenugreek (Trigonella foenum-graecum) seeds in the domestic rabbit (Oryctolagus cuniculus)

Research Journal of Medicinal Plant

Volumn 6, Issue 6, 2012, Pages 449-455

  Abdelatif, Abdalla M ^a   Ibrahim, Mariam Y ^b   Mahmoud, Amal S ^c  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b OMDURMAN ISLAMIC UNIVERSITY   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Alloxan diabetes; Fenugreek; Insulin; Rabbits

Indexed keywords

CHOLESTEROL; GLUCOSE; HERBACEOUS AGENT; INSULIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOMESTIC ANIMAL; DRUG SCREENING; FENUGREEK; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; ORYCTOLAGUS CUNICULUS; PLANT SEED; RABBIT; SUPPLEMENTATION;

ORYCTOLAGUS CUNICULUS; TRIGONELLA FOENUM-GRAECUM;

EID: 84864046571     PISSN: 18193455     EISSN: 21517924     Source Type: Journal    
DOI: 10.3923/rjmp.2012.449.455     Document Type: Article

References (26)

1. Al-Habori, M. and A. Raman, 1998. Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytother. Res., 12: 233-242.
2. Al-Habori, M., A. Raman, M.J. Laurence and P. Skett, 2001. In vitro effect of fenugreek extracts on intestinal sodium-dependent glucose uptake and hepatic glycogen phosphorylase A. Int. J. Exp. Diabetes Res., 2: 91-99.
3. American Diabetes Association, 2009. Diagnosis and classification of diabetes mellitus. Diabetes Care, 32: S62-S67.
4. Baquer, N.Z., P. Kumar, A. Taha, R.K. Kale, S.M. Cowsik and P. Mclean, 2011. Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetes tissues. J. Biosci., 36: 383-396.
5. Basch, E., C. Ulbricht, G. Kuo, P. Szapary and M. Smith, 2003. Therapeutic applications of fenugreek. Altern. Med. Rev., 8: 20-27.
6. Brinker, F.J., 1998. Herb Contraindications and Drug Interactions: With Appendices Addressing Specific Conditions and Medicines. 2nd Edn., Eclectic Medical Publications, Oregon, USA., ISBN: 9781888483062, Pages: 263.
7. Hannan, J.M., L. Ali, B. Rokeya, J. Khaleque and M. Akhter et al., 2007. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption and enhancing insulin action. Br. J. Nutr., 97: 514-521.
8. Hollenbeck, C.B., 1993. Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. Am. J. Clin. Nutr., 58: 800S-809S.
9. Kassem, A., A. Al-Aghbari, M. Al-Habori and M. Al-Mamary, 2006. Evaluation of the potential antifertility effect of fenugreek seeds in male and female rabbits. Contraception, 73: 301-306.
10. Khalki, L., S.B. M'hamed, M. Bennis, A. Chait and Z. Sokar, 2010. Evaluation of the developmental toxicity of the aqueous extract from Trigonella foenum-graecum (L.) in mice. J. Ethnopharmacol., 131: 321-325.
11. Nelson, R.W., S.L. Ihle, L.D. Lewis, S.K. Salisbury, T. Miller, V. Bergdall and G.D. Bottoms, 1991. Effects of dietary fibre supplementation on glycaemic control in dogs with alloxan-induced diabetes mellitus. Am. J. Vet. Res., 52: 2060-2066.
12. Park, M.Y., K.S. Lee and M.K. Sung, 2005. Effects of dietary mulberry, Korean red ginseng and banaba on glucose homeostasis in relation to PPAK-α, PPAR-γ and LPL mRNA expressions. Life Sci, 77: 3344-3354.
13. Prasanna, M., 2000. Hypolipidaemic effect of fenugreek: A clinical study. Indian J. Pharmacol., 32: 34-36.
14. Raju, J., D. Gupta, A.R. Rao, P.K. Yadava and N.Z. Baquer, 2001. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol. Cell Biochem., 224: 45-51.
15. Ribes, G., Y. Sauvaire, C. DaCosta, J.C. Baccou and M.M. Loubatieres-Mariani, 1986. Antidiabetic effects of sub fractions from fenugreek seeds in diabetic dogs. Proc. Soc. Exp. Biol. Med., 182: 159-166.
16. SAS Institute, 1996. SAS/STAT Users Guide: Statistics. Version 7, SAS Institute, Inc., Cary, NC., USA.
17. Satyanarayana, S., K.E. Kumar, J. Rajasekhar, L. Thomas, S. Rajanna and B. Rajanna, 2007. Influence of aqueous extract of fenugreek-seed powder on the pharmacodynamics and pharmacokinetics of gliclazide in rats/rabbits. Therapy, 4: 457-463.
18. Sauvaire, Y., G. Ribes, J.C. Baccou and M.M. Loubatieres-Mariani, 1991. Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek. Lipids, 26: 191-197.
19. Sauvaire, Y., P. Petit, C. Broca, M. Manteghetti and Y. Baissac et al., 1998. 4-hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes, 47: 206-210.
20. Sauvaire, Y., Y. Baissac, O. Laconte, P. Petit and G. Ribes, 1996. Steroid saponins from fenugreek and some of their biological properties. Adv. Exp. Med. Biol., 405: 37-46.
21. Srinivasan, K., 2006. Fenugreek (Trigonella foenum-graecum). A review of health beneficial physiological effects. Food Rev. Int., 22: 203-224.
22. Swanston-Flatt, S.K., C. Day, P.R. Flatt, B.J. Gould and C.J. Bailey, 1989. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res., 10: 69-73.
23. Szkudelski, T., K. Kandulska and M. Okulicz, 1998. Alloxan in vivo does not only exert deleterious effects on pancreatic beta cells. Physiol. Res., 47: 343-346.
24. Thakran, S., M.R. Siddiqui and N.Z. Baquer, 2004. Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats. Mol. Cell. Biochem., 266: 151-159.
25. Vijayakumar, M.V., S. Singh, R.R. Chhipa and M.K. Bhat, 2005. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Breed. J. Pharmacol., 146: 41-48.
26. Yin, W., Z. Yuan, K. Tsutsumi, Y. Xie and Q. Zhang et al., 2003. A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits. Exp. Diabesity Res., 4: 27-34.